Latest Breaking News On - Kukbo co - Page 1 : vimarsana.com

Form F-3 RedHill Biopharma Ltd.

RedHill Biopharma : Reprice and Reload Offer of Ordinary Share Purchase Warrants - Form 6-K -September 29, 2023 at 10:53 am EDT

Reprice and Reload Offer of Ordinary Share Purchase Warrants To Whom It May Concern: RedHill...

RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights

RHB-107 included in the U.S. Department of Defense-supported ACESO PROTECT multinational platform trial for early COVID-19 outpatient treatment; The...

RedHill Biopharma : SECURITIES PURCHASE AGREEMENT

SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of July __, 2023, between RedHill Biopharma Ltd., a company organized under the laws...

RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights

Q1/23 Talicia net revenues of $3.4 million; Cash balance of $28.8 million as of March 31, 2023[1]; Extinguishment of all debt obligations in exchange for the...

RedHill Biopharma : SECURITIES PURCHASE AGREEMENT - Form 6-K

SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of March ___, 2023, between RedHill Biopharma Ltd., a company organized under the... | April 3, 2023

RedHill Biopharma Announces Q3/22 Results and Operational Highlights

Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt obligations, to facilitate growth Q3/22 Net revenues of $17.6...

RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates

Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:...

RedHill Biopharma (RDHL) Provides H1'22 Highlights and Q3 Estimates

RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates

Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:...